These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 24072747)

  • 21. CIP2A inhibits PP2A in human malignancies.
    Junttila MR; Puustinen P; Niemelä M; Ahola R; Arnold H; Böttzauw T; Ala-aho R; Nielsen C; Ivaska J; Taya Y; Lu SL; Lin S; Chan EK; Wang XJ; Grènman R; Kast J; Kallunki T; Sears R; Kähäri VM; Westermarck J
    Cell; 2007 Jul; 130(1):51-62. PubMed ID: 17632056
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genistein targets the cancerous inhibitor of PP2A to induce growth inhibition and apoptosis in breast cancer cells.
    Zhao Q; Zhao M; Parris AB; Xing Y; Yang X
    Int J Oncol; 2016 Sep; 49(3):1203-10. PubMed ID: 27574003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CIP2A mediates effects of bortezomib on phospho-Akt and apoptosis in hepatocellular carcinoma cells.
    Chen KF; Liu CY; Lin YC; Yu HC; Liu TH; Hou DR; Chen PJ; Cheng AL
    Oncogene; 2010 Nov; 29(47):6257-66. PubMed ID: 20729919
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancerous inhibitor of protein phosphatase 2A (CIP2A) protein is involved in centrosome separation through the regulation of NIMA (never in mitosis gene A)-related kinase 2 (NEK2) protein activity.
    Jeong AL; Lee S; Park JS; Han S; Jang CY; Lim JS; Lee MS; Yang Y
    J Biol Chem; 2014 Jan; 289(1):28-40. PubMed ID: 24214971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cucurbitacin B induces inhibitory effects via the CIP2A/PP2A/C-KIT signaling axis in t(8;21) acute myeloid leukemia.
    Ma W; Xiang Y; Yang R; Zhang T; Xu J; Wu Y; Liu X; Xiang K; Zhao H; Liu Y; Si Y
    J Pharmacol Sci; 2019 Apr; 139(4):304-310. PubMed ID: 30852180
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dissecting cellular responses to irradiation via targeted disruptions of the ATM-CHK1-PP2A circuit.
    Palii SS; Cui Y; Innes CL; Paules RS
    Cell Cycle; 2013 Apr; 12(7):1105-18. PubMed ID: 23462183
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mitotic DNA damage response: Polo-like kinase-1 is dephosphorylated through ATM-Chk1 pathway.
    Lee HJ; Hwang HI; Jang YJ
    Cell Cycle; 2010 Jun; 9(12):2389-98. PubMed ID: 20581453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cucurbitacin B reverses multidrug resistance by targeting CIP2A to reactivate protein phosphatase 2A in MCF-7/adriamycin cells.
    Cai F; Zhang L; Xiao X; Duan C; Huang Q; Fan C; Li J; Liu X; Li S; Liu Y
    Oncol Rep; 2016 Aug; 36(2):1180-6. PubMed ID: 27350399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CIP2A facilitates the G1/S cell cycle transition via B-Myb in human papillomavirus 16 oncoprotein E6-expressing cells.
    Tian Y; Chen H; Qiao L; Zhang W; Zheng J; Zhao W; Chen JJ; Zhang W
    J Cell Mol Med; 2018 Sep; 22(9):4150-4160. PubMed ID: 29893470
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Micropeptide CIP2A-BP encoded by LINC00665 inhibits triple-negative breast cancer progression.
    Guo B; Wu S; Zhu X; Zhang L; Deng J; Li F; Wang Y; Zhang S; Wu R; Lu J; Zhou Y
    EMBO J; 2020 Jan; 39(1):e102190. PubMed ID: 31755573
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cucurbitacin B induces autophagy and apoptosis by suppressing CIP2A/PP2A/mTORC1 signaling axis in human cisplatin resistant gastric cancer cells.
    Liu X; Duan C; Ji J; Zhang T; Yuan X; Zhang Y; Ma W; Yang J; Yang L; Jiang Z; Yu H; Liu Y
    Oncol Rep; 2017 Jul; 38(1):271-278. PubMed ID: 28534965
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Leucine-rich repeat-containing protein 59 mediates nuclear import of cancerous inhibitor of PP2A in prostate cancer cells.
    Pallai R; Bhaskar A; Barnett-Bernodat N; Gallo-Ebert C; Pusey M; Nickels JT; Rice LM
    Tumour Biol; 2015 Aug; 36(8):6383-90. PubMed ID: 25833693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genistein Decreases APP/tau Phosphorylation and Ameliorates Aβ Overproduction Through Inhibiting CIP2A.
    Shentu YP; Hu WT; Liang JW; Liuyang ZY; Wei H; Qun W; Wang XC; Wang JZ; Westermarck J; Liu R
    Curr Alzheimer Res; 2019; 16(8):732-740. PubMed ID: 31470788
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cancerous inhibitor of PP2A (CIP2A) at diagnosis of chronic myeloid leukemia is a critical determinant of disease progression.
    Lucas CM; Harris RJ; Giannoudis A; Copland M; Slupsky JR; Clark RE
    Blood; 2011 Jun; 117(24):6660-8. PubMed ID: 21490338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of cancerous inhibitor ofPP2A (
    Hasanin R; Mossallam G; Elfishawi S; Rabea A; Hamdy N
    Expert Rev Hematol; 2022 May; 15(5):465-471. PubMed ID: 35502616
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Over-expression of cancerous inhibitor of PP2A (CIP2A) in bone marrow cells from patients with a group of high-risk myelodysplastic syndromes.
    Li N; Abe S; Kurata M; Abe-Suzuki S; Onishi I; Kirimura S; Murayama T; Hidaka M; Kawano F; Kitagawa M
    Pathol Oncol Res; 2014 Apr; 20(2):399-407. PubMed ID: 24163288
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cancerous inhibitor of protein phosphatase 2A (CIP2A) modifies energy metabolism via 5' AMP-activated protein kinase signalling in malignant cells.
    Austin JA; Jenkins RE; Austin GM; Glenn MA; Dunn K; Scott L; Lucas CM; Clark RE
    Biochem J; 2019 Aug; 476(15):2255-2269. PubMed ID: 31350330
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PP2A and E3 ubiquitin ligase deficiencies: Seminal biological drivers in endometrial cancer.
    Gonzalez-Bosquet J; Bakkum-Gamez JN; Weaver AL; McGree ME; Dowdy SC; Famuyide AO; Kipp BR; Halling KC; Couch FJ; Podratz KC
    Gynecol Oncol; 2021 Jul; 162(1):182-189. PubMed ID: 33867147
    [TBL] [Abstract][Full Text] [Related]  

  • 39. (+)-Cyanidan-3-ol inhibits epidermoid squamous cell carcinoma growth via inhibiting AKT/mTOR signaling through modulating CIP2A-PP2A axis.
    Monga J; Suthar SK; Rohila D; Joseph A; Chauhan CS; Sharma M
    Phytomedicine; 2022 Jul; 101():154116. PubMed ID: 35525235
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CIP2A modulates cell-cycle progression in human cancer cells by regulating the stability and activity of Plk1.
    Kim JS; Kim EJ; Oh JS; Park IC; Hwang SG
    Cancer Res; 2013 Nov; 73(22):6667-78. PubMed ID: 23983103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.